FB
Francesca Barone
Chief Scientific Officer

Francesca Barone insider trades: Candel Therapeutics (CADL) stock buys and sales

Chief Scientific Officer, Candel Therapeutics Last trade Jun 29, 2026 17 Form 4 filings
$236K
Sold, last 12 months
1 sale
$0
Bought, last 12 months
0 buys
8
Open-market trades
since 2022
1
Company
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Francesca reports to the SEC

Open-market buys and sales

8 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jun 29, 2026CADL↓ Sell$236K
Mar 18, 2025CADL↓ Sell$282K
Jan 15, 2025CADL↓ Sell$98K
Jan 8, 2025CADL↓ Sell$112K
Nov 29, 2024CADL↓ Sell$101K
Jul 17, 2024CADL↓ Sell$91K
Jul 11, 2024CADL↓ Sell$76K
Dec 8, 2022CADL↑ Buy$2K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other CADL insiders

Open-market trades in the last 12 months

About Francesca Barone's insider trades

Francesca Barone is Chief Scientific Officer at Candel Therapeutics (CADL). Since Dec 8, 2022, Francesca has reported 1 open-market purchase worth $2K and 7 sales worth $995K on SEC Form 4. In the last 12 months: 1 sale ($236K).

Their filings also include grants and awards (8 filings), option exercises (1 filing), shares withheld for taxes (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CADL insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.